Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/4/2020
SIETES contiene 92957 citas

 
 
 1 a 20 de 41 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Savage RD, Visentin JD, Bronskill SE, Wang X, Gruneir A, Giannakeas V, Guan J, Lam K, Luke MJ, Read SH, Stall NM, Wu W, Zhu L, Rochon PA, McCarthy LM. Evaluation of a common prescribing cascade of calcium channel blockers and diuretics in older adults with hypertension. JAMA Intern Med 2020:24 de febrero. [Ref.ID 103548]
2. Cita con resumen
Ali S, Peterson GM, Bereznicki LR, Salahudeen MS. Association between anticholinergic drug burden and mortality in older people: a systematic review. Eur J Clin Pharmacol 2020;76:319-35. [Ref.ID 103529]
3.Enlace a cita original Cita con resumen
Pérez T, Moriarty F, Wallace E, McDowell R, Redmond P, Fahey T. Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study. BMJ 2018;363:14 de noviembre. [Ref.ID 102868]
4. Cita con resumen
Welch HG, Prorok PC, O'Malley AJ, Kramer BS. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med 2016;375:1438-47. [Ref.ID 100802]
5. Cita con resumen
6. Cita con resumen
Arie S. Switzerland debates dismantling its breast cancer screening programme. BMJ 2014;348:g1625. [Ref.ID 97327]
7. Cita con resumen
Geller AI, Shehab N, Lovegrove MC, Kegler SR, Weidenbach KN, Ryan GJ, Budnitz DS. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med 2014;174:678-86. [Ref.ID 97300]
8.Tiene citas relacionadas Cita con resumen
Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening — Authors' reply. Lancet 2013;381:803-4. [Ref.ID 95084]
9.Tiene citas relacionadas Cita con resumen
Gotzsche PC, Jorgensen KJ. The benefits and harms of breast cancer screening. Lancet 2013;381:799. [Ref.ID 95083]
10. Cita con resumen
Baum M. Harms from breast cancer screening outweigh benefits. BMJ 2013;346:27. [Ref.ID 94837]
11.Enlace a cita original
Perfect JR. Iatrogenic fungal meningitis: tragedy repeated. Ann Intern Med 2012;157:825-6. [Ref.ID 94184]
12. Cita con resumen
Hawkes N. Breast screening is beneficial but women need more information. BMJ 2012;345:1. [Ref.ID 93997]
13. Cita con resumen
Watts G. Thomas Stephen Szasz. Lancet 2012;380:1380. [Ref.ID 93898]
14. Cita con resumen
Gyllensten H, Jönsson AK, Rehnberg C, Carlsten A. How are the costs of drug-related morbidity measured? A systematic literature review. Drug Saf 2012;35:207-19. [Ref.ID 92431]
15. Cita con resumen
Bates DW, Larizgoitia I, Prasopa-Plaizier N, Jha AK. Global priorities for patient safety research. BMJ 2009;338:1242-4. [Ref.ID 85967]
16. Cita con resumen
Ligi I, Arnaud F, Jouve E, Tardieu S, Sambuc R, Simeoni U. Iatrogenic events in admitted neonates: a prospective cohort study. Lancet 2008;371:404-10. [Ref.ID 82123]
17.
Budnitz DS, Layde PM. Outpatient drug safety: new steps in an old direction. Pharmacoepidemiol Drug Saf 2007;16:160-5. [Ref.ID 79335]
18. Cita con resumen
Prati D. Non-sterile injections, contaminated blood, and the spread of HIV. Lancet 2006;368:1064-5. [Ref.ID 78147]
19. Cita con resumen
Jyrkkä J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75-Study. Eur J Clin Pharmacol 2006;62:151-8. [Ref.ID 76350]
20. Cita con resumen
Pui C-H, Relling M V. Can the genotoxicity of chemotherapy be predicted?. Lancet 2004;364:917-8. [Ref.ID 71311]
Seleccionar todas
 
 1 a 20 de 41 siguiente >>